Home » Topics » Regulatory

Regulatory
RSS

New nondrug treatment approved for rheumatoid arthritis in Canada

March 10, 2000

New formulation of Agouron's Viracept approved in U.S.

March 10, 2000

Pharmacia & Upjohn submits applications for once-daily Detrol formulation

March 10, 2000

AMBI to receive patent for use of calcium taurate with antihypertensive agents

March 10, 2000

The FDA approves once-daily Singulair tablet for treatment of asthma in young children

March 9, 2000

Solid oral formulations of eprosartan with enhanced bioavailability

March 9, 2000

Use of secretin for autism receives broad patent coverage

March 7, 2000

European mutual recognition approval obtained for candesartan/HCTZ combination

March 7, 2000

Noven successfully completes phase II study of MethyPatch for treatment of ADHD

March 3, 2000

Novantrone moves one step closer to approval for MS

March 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.